Revenue for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current revenue (TTM) is $96.68B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$96.68B
YoY change
+6.0%
5Y CAGR
+2.7%
Peak year (2025)
$94.19B
Cumulative revenue
$1.93T
Revenue history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Revenue history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | Revenue | YoY |
|---|---|---|---|---|
| 2025 | $94.19B | +6.0% | ||
| 2024 | $88.82B | +4.3% | ||
| 2023 | $85.16B | +6.5% | ||
| 2022 | $79.99B | +1.6% | ||
| 2021 | $78.74B | -4.7% | ||
| 2020 | $82.58B | +0.6% | ||
| 2019 | $82.06B | +0.6% | ||
| 2018 | $81.58B | +6.7% | ||
| 2017 | $76.45B | +6.3% | ||
| 2016 | $71.89B | +2.6% | ||
| 2015 | $70.07B | -5.7% | ||
| 2014 | $74.33B | +4.2% | ||
| 2013 | $71.31B | +6.1% | ||
| 2012 | $67.22B | +3.4% | ||
| 2011 | $65.03B | +5.6% | ||
| 2010 | $61.59B | -0.5% | ||
| 2009 | $61.90B | -2.9% | ||
| 2008 | $63.75B | +4.3% | ||
| 2007 | $61.09B | +14.6% | ||
| 2006 | $53.32B | +5.6% | ||
| 2005 | $50.51B | +6.7% | ||
| 2004 | $47.35B | +13.1% | ||
| 2003 | $41.86B | +15.3% | ||
| 2002 | $36.30B | +12.3% | ||
| 2001 | $32.32B | +10.8% | ||
| 2000 | $29.17B | +4.2% | ||
| 1999 | $28.01B | +16.7% | ||
| 1998 | $24.00B | +6.0% | ||
| 1997 | $22.63B | +4.7% | ||
| 1996 | $21.62B | +14.7% | ||
| 1995 | $18.84B | +19.8% | ||
| 1994 | $15.73B | +11.3% | ||
| 1993 | $14.14B | +2.8% | ||
| 1992 | $13.75B | +10.5% | ||
| 1991 | $12.45B | +10.8% | ||
| 1990 | $11.23B | +15.1% | ||
| 1989 | $9.76B | +8.4% | ||
| 1988 | $9.00B | +12.3% | ||
| 1987 | $8.01B | +14.4% | ||
| 1986 | $7.00B | +9.1% | ||
| 1985 | $6.42B | — |
Revenue values are taken from Johnson & Johnson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Johnson & Johnson (JNJ) most recent annual revenue stands at $94.19B (2025) – grew 6.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Johnson & Johnson revenue compounded at +2.7% per year, sustaining 4 straight years of year-over-year growth.
The highest annual revenue of $94.19B was reported in 2025. The lowest in the available history was $6.42B in 1985.
Johnson & Johnson (JNJ) sits 3rd of 8 Healthcare peers we track on this metric, against a peer median of $63.09B.
Johnson & Johnson Revenue by Year
Johnson & Johnson Revenue 2025: $94.19B
Johnson & Johnson revenue in 2025 was $94.19B, grew 6.0% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Revenue 2024: $88.82B
Johnson & Johnson revenue in 2024 was $88.82B, edged up 4.3% from 2023.
Johnson & Johnson Revenue 2023: $85.16B
Johnson & Johnson revenue in 2023 was $85.16B, grew 6.5% from 2022.
Johnson & Johnson Revenue 2022: $79.99B
Johnson & Johnson revenue in 2022 was $79.99B, edged up 1.6% from 2021.
Johnson & Johnson Revenue 2021: $78.74B
Johnson & Johnson revenue in 2021 was $78.74B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — Revenue
Companies in the same sector as Johnson & Johnson, ranked by their latest revenue.
| Company | Revenue | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $447.57B | Healthcare |
| Novo Nordisk A/S (NVO) | $309.06B | Healthcare |
| Eli Lilly and Company (LLY) | $65.18B | Healthcare |
| Merck & Co., Inc. (MRK) | $65.01B | Healthcare |
| AbbVie Inc. (ABBV) | $61.16B | Healthcare |
| AstraZeneca PLC (AZN) | $58.74B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $44.56B | Healthcare |
| Amgen Inc. (AMGN) | $36.74B | Healthcare |
Frequently asked questions
What is Johnson & Johnson's revenue?
- Latest reported revenue for Johnson & Johnson (JNJ) is $96.68B (period ending March 31, 2026).
How has Johnson & Johnson revenue changed year-over-year?
- Johnson & Johnson (JNJ) revenue changed +6.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson revenue?
- Johnson & Johnson (JNJ) revenue compound annual growth rate is +2.7% over the most recent 5 years available.
When did Johnson & Johnson revenue hit its highest annual value?
- Johnson & Johnson revenue reached its highest annual value of $94.19B in 2025.
What was Johnson & Johnson revenue in 2024?
- Johnson & Johnson (JNJ) revenue in 2024 was $88.82B.
What was Johnson & Johnson revenue in 2025?
- Johnson & Johnson (JNJ) revenue in 2025 was $94.19B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.